ArticleJournal of clinical medicine2019

Embelin as a Novel Inhibitor of PKC in the Prevention of Platelet Activation and Thrombus Formation.

Jiun Yi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.